Sanofi taps Exscientia for a deal worth up to $5.2B | MobiHealthNews | mobihealthnews.com 2022/01/10 ... Biopharma giant Sanofi is setting its sights on AI for drug discovery, inking a deal worth more than $100 million with tech company Exscientia. https://www.mobihealthnews.com/news/sanofi-taps-exscienta-deal-worth-52b
Andrew Hopkins of Exscientia: the man using AI to cure disease | theguardian.com 2022/07/30 ... Typically, pharma companies make 2,500 compounds to test them against a specific disease, while AI enables Oxford-based Exscientia to ... https://www.theguardian.com/business/2022/jul/30/andrew-hopkins-of-exscientia-the-man-using-...
Exscientia | Mubadala | mubadala.com Their mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with ... https://www.mubadala.com/en/what-we-do/exscientia
Sanofi signs drug development partnership with Exscientia worth up ... | fortune.com 2022/01/07 ... Sanofi, the Paris-based pharmaceutical giant, has signed a research collaboration with Exscientia, which uses artificial intelligence to ... https://fortune.com/2022/01/07/sanofi-excientia-ai-drug-development-deal/
Exscientia – $510.4 Million IPO // Cooley // Global Law Firm | cooley.com 2021/10/05 ... London – October 5, 2021 – Cooley advised Exscientia, an AI-driven pharmatech company based in Oxford, United Kingdom, on its $510.4 million ... https://www.cooley.com/news/coverage/2021/2021-10-05-exscientia-510-4-million-ipo
Exscientia Plc - Company Profile and News - Bloomberg Markets | bloomberg.com ... for Exscientia Plc including stock price, company news, press releases, ... The Company develops an artificial intelligence-designed drug candidates to ... https://www.bloomberg.com/profile/company/1541245D:LN
Exscientia Company Profile - Office Locations, Competitors ... - Craft.co | craft.co Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. It offers the Patient-First AI oncology platform ... https://craft.co/exscientia
Exscientia to Present at Upcoming Investor Conferences in September | businesswirechina.com 2022/09/08 ... OXFORD, England--(BUSINESS WIRE)--Exscientia (Nasdaq: EXAI) today ... under the “Investors &Media” section at www.investors.exscientia.ai. https://www.businesswirechina.com/en/news/51471.html
Building AI for the Drug Discovery Learning Problem - Bio-IT World | bio-itworld.com 2022/10/19 ... Even when there are approved AI-designed drugs, companies like his will still need to show their work. Encode and Automate. Exscientia, Law ... https://www.bio-itworld.com/news/2022/10/19/building-ai-for-the-drug-discovery-learning-problem